Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$422M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$411M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$351M |
| 4 |
Pfizer
PFE
|
+$331M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.28B |
| 2 |
Meta Platforms (Facebook)
META
|
+$989M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$953M |
| 4 |
Amazon
AMZN
|
+$816M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$782M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.23% |
| 2 | Technology | 2.06% |
| 3 | Consumer Discretionary | 1.41% |
| 4 | Healthcare | 0.83% |
| 5 | Financials | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LLAP
11601
CALL
DELISTED
Terran Orbital Corporation
LLAP
| $57.7K | ﹤0.01% |
+50,600
| New | +$42.3K |
|
11602
Mustang Bio
MBIO
$4.17M
| $57.5K | ﹤0.01% |
852
+200
| +31% | +$15.9K |
|
|
ASXC
11603
CALL
DELISTED
Asensus Surgical, Inc.
ASXC
| $57.5K | ﹤0.01% |
179,800
-14,100
| -7% | -$3.63K |
|
|
WOW
11604
CALL
DELISTED
WideOpenWest
WOW
| $57.5K | ﹤0.01% |
+14,200
| New | +$76.4K |
|
|
DRRX
11605
CALL
DELISTED
DURECT Corp
DRRX
| $57.5K | ﹤0.01% |
97,400
-101,500
| -51% | -$145K |
|
11606
PUT
Delcath Systems
DCTH
$569M
| $57.4K | ﹤0.01% |
13,800
-14,600
| -51% | -$47.8K |
|
11607
NewAmsterdam Pharma Warrant
NAMSW
| $57.3K | ﹤0.01% |
+18,319
| New | +$35.9K |
|
11608
ProKidney
PROK
$380M
| $57.3K | ﹤0.01% |
+32,196
| New | +$69K |
|
11609
CALL
Caesarstone
CSTE
$111M
| $57.2K | ﹤0.01% |
+15,300
| New | +$61.7K |
|
|
BCOV
11610
DELISTED
Brightcove, Inc.
BCOV
| $57K | ﹤0.01% |
+22,025
| New | +$59.1K |
|
11611
Werewolf Therapeutics
HOWL
$47.2M
| $57K | ﹤0.01% |
+14,777
| New | +$37.7K |
|
|
KRON
11612
DELISTED
Kronos Bio
KRON
| $56.8K | ﹤0.01% |
+45,443
| New | +$50.3K |
|
11613
CALL
CarParts.com
PRTS
$55.1M
| $56.6K | ﹤0.01% |
1,790
-230
| -11% | -$7.77K |
|
11614
Zura Bio
ZURA
$561M
| $56.2K | ﹤0.01% |
+12,037
| New | +$60.2K |
|
11615
PUT
NextNav
NN
$2.65B
| $56.1K | ﹤0.01% |
12,600
-39,000
| -76% | -$176K |
|
|
NBP
11616
NovaBridge Biosciences American Depositary Shares
NBP
$219M
| $55.8K | ﹤0.01% |
29,365
-20,804
| -41% | -$31.1K |
|
11617
CALL
Rockwell Medical
RMTI
$31.2M
| $55.8K | ﹤0.01% |
2,950
+150
| +5% | +$2.82K |
|
|
KGEI
11618
Kolibri Global Energy
KGEI
$210M
| $55.6K | ﹤0.01% |
+15,455
| New | +$64.5K |
|
11619
CALL
Ribbon Communications
RBBN
$358M
| $55.4K | ﹤0.01% |
+19,100
| New | +$43K |
|
11620
Design Therapeutics
DSGN
$954M
| $55.4K | ﹤0.01% |
20,896
-1,641
| -7% | -$3.76K |
|
11621
IT Tech Packaging
ITP
$3.06M
| $55K | ﹤0.01% |
177,352
+46,041
| +35% | +$14.9K |
|
|
APLT
11622
PUT
DELISTED
Applied Therapeutics
APLT
| $54.9K | ﹤0.01% |
+16,400
| New | +$40.8K |
|
|
TIO
11623
DELISTED
Tingo Group, Inc. Common Stock
TIO
| $54.7K | ﹤0.01% |
79,309
+24,934
| +46% | +$20.1K |
|
11624
PUT
Senseonics Holdings Inc
SENS
$497M
| $54.6K | ﹤0.01% |
4,790
-10,975
| -70% | -$125K |
|
11625
CALL
Atea Pharmaceuticals
AVIR
$437M
| $54.6K | ﹤0.01% |
17,900
+7,900
| +79% | +$23.9K |
|
Similar funds
Jeff Yass's Q4 2023 Portfolio in Review
As of Q4 2023, Jeff Yass held 13,823 positions worth $525B, up 9.3% from $481B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2023 filing shows 1,903 new, 5,066 increased, 5,122 reduced and 1,577 closed positions. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.28B.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2023 buy was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M.
- Jeff Yass added most to Alibaba in Q4 2023, an estimated $422M increase.
- Jeff Yass's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.28B.
- Jeff Yass fully exited VMware, Inc in Q4 2023, selling an estimated $313M.
- Jeff Yass's ten largest holdings make up 24% of its $525B portfolio in Q4 2023.
- Jeff Yass opened 1,903 new positions and closed 1,577 in Q4 2023.
- Jeff Yass's portfolio value rose 9.3% quarter-over-quarter to $525B.
Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.